The Procter & Gamble Company (PG) 10-Q 22 Jan 25 2025 Q2 Quarterly report Financial data

Cover Page

Cover Page	6 Months Ended
	Dec. 31, 2024 shares
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2024
Document Transition Report	false
Entity Registrant Name	PROCTER & GAMBLE CO
Entity Incorporation, State or Country Code	OH
Entity File Number	1-434
Entity Tax Identification Number	31-0411980
Entity Address, Address Line One	One Procter & Gamble Plaza
Entity Address, State or Province	Cincinnati
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	45202
City Area Code	513
Local Phone Number	983-1100
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	2,344,851,814
Entity Central Index Key	0000080424
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q2
Amendment Flag	false
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, without Par Value
Trading Symbol	PG
Security Exchange Name	NYSE
1.375% Notes due 2025
Entity Information [Line Items]
Title of 12(b) Security	1.375% Notes due 2025
Trading Symbol	PG25
Security Exchange Name	NYSE
0.110% Notes due 2026
Entity Information [Line Items]
Title of 12(b) Security	0.110% Notes due 2026
Trading Symbol	PG26D
Security Exchange Name	NYSE
3.250% EUR Notes due 2026
Entity Information [Line Items]
Title of 12(b) Security	3.250% EUR Notes due 2026
Trading Symbol	PG26F
Security Exchange Name	NYSE
4.875% EUR Notes due May 2027
Entity Information [Line Items]
Title of 12(b) Security	4.875% EUR Notes due May 2027
Trading Symbol	PG27A
Security Exchange Name	NYSE
1.200% Notes due 2028
Entity Information [Line Items]
Title of 12(b) Security	1.200% Notes due 2028
Trading Symbol	PG28
Security Exchange Name	NYSE
3.150% EUR Notes due 2028
Entity Information [Line Items]
Title of 12(b) Security	3.150% EUR Notes due 2028
Trading Symbol	PG28B
Security Exchange Name	NYSE
1.250% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.250% Notes due 2029
Trading Symbol	PG29B
Security Exchange Name	NYSE
1.800% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.800% Notes due 2029
Trading Symbol	PG29A
Security Exchange Name	NYSE
6.250% GBP Notes due January 2030
Entity Information [Line Items]
Title of 12(b) Security	6.250% GBP Notes due January 2030
Trading Symbol	PG30
Security Exchange Name	NYSE
0.350% Notes due 2030
Entity Information [Line Items]
Title of 12(b) Security	0.350% Notes due 2030
Trading Symbol	PG30C
Security Exchange Name	NYSE
0.230% Notes due 2031
Entity Information [Line Items]
Title of 12(b) Security	0.230% Notes due 2031
Trading Symbol	PG31A
Security Exchange Name	NYSE
3.250% EUR Notes due 2031
Entity Information [Line Items]
Title of 12(b) Security	3.250% EUR Notes due 2031
Trading Symbol	PG31B
Security Exchange Name	NYSE
5.250% GBP Notes due January 2033
Entity Information [Line Items]
Title of 12(b) Security	5.250% GBP Notes due January 2033
Trading Symbol	PG33
Security Exchange Name	NYSE
3.200% EUR Notes due 2034
Entity Information [Line Items]
Title of 12(b) Security	3.200% EUR Notes due 2034
Trading Symbol	PG34C
Security Exchange Name	NYSE
1.875% Notes due 2038
Entity Information [Line Items]
Title of 12(b) Security	1.875% Notes due 2038
Trading Symbol	PG38
Security Exchange Name	NYSE
0.900% Notes due 2041
Entity Information [Line Items]
Title of 12(b) Security	0.900% Notes due 2041
Trading Symbol	PG41
Security Exchange Name	NYSE

Consolidated Statements of Earn

Consolidated Statements of Earnings - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
NET SALES		$ 21,882	$ 21,441	$ 43,619	$ 43,312
Cost of products sold		10,418	10,144	20,839	20,645
Selling, general and administrative expense		5,723	5,522	11,242	11,127
Indefinite-lived intangible asset impairment charge		0	1,341	0	1,341
OPERATING INCOME		5,741	4,433	11,538	10,200
Interest expense		(240)	(248)	(478)	(472)
Interest income		119	133	254	262
Other non-operating income/(expense), net		224	177	(330)	309
EARNINGS BEFORE INCOME TAXES		5,845	4,496	10,985	10,299
Income taxes		1,187	1,003	2,339	2,250
NET EARNINGS		4,659	3,493	8,646	8,049
Less: Net earnings attributable to noncontrolling interests		29	25	56	60
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE		$ 4,630	$ 3,468	$ 8,589	$ 7,988
NET EARNINGS PER COMMON SHARE
Basic (in dollars per share)	[1]	$ 1.94	$ 1.44	$ 3.59	$ 3.33
Diluted (in dollars per share)	[1]	$ 1.88	$ 1.40	$ 3.49	$ 3.23
[1] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Statement of Comprehensive Income [Abstract]
NET EARNINGS	$ 4,659	$ 3,493	$ 8,646	$ 8,049
OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX
Foreign currency translation	(770)	492	256	83
Unrealized gains/(losses) on investment securities	0	(1)	1	(2)
Unrealized gains/(losses) on defined benefit postretirement plans	24	(75)	3	(30)
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX	(747)	416	260	51
TOTAL COMPREHENSIVE INCOME	3,912	3,909	8,906	8,100
Less: Comprehensive income attributable to noncontrolling interests	26	25	54	58
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE	$ 3,887	$ 3,884	$ 8,852	$ 8,041

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
CURRENT ASSETS
Cash and cash equivalents	$ 10,230	$ 9,482
Accounts receivable	6,234	6,118
INVENTORIES
Materials and supplies	1,949	1,617
Work in process	879	929
Finished goods	4,192	4,470
Total inventories	7,020	7,016
Prepaid expenses and other current assets	2,158	2,095
TOTAL CURRENT ASSETS	25,642	24,709
PROPERTY, PLANT AND EQUIPMENT, NET	22,074	22,152
GOODWILL	39,898	40,303
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET	21,833	22,047
OTHER NONCURRENT ASSETS	13,192	13,158
TOTAL ASSETS	122,639	122,370
CURRENT LIABILITIES
Accounts payable	14,495	15,364
Accrued and other liabilities	9,879	11,073
Debt due within one year	9,424	7,191
TOTAL CURRENT LIABILITIES	33,797	33,627
LONG-TERM DEBT	25,263	25,269
DEFERRED INCOME TAXES	6,725	6,516
OTHER NONCURRENT LIABILITIES	5,411	6,398
TOTAL LIABILITIES	71,195	71,811
SHAREHOLDERS’ EQUITY
Preferred stock	788	798
Common stock	4,009	4,009
Additional paid-in capital	68,283	67,684
Reserve for ESOP debt retirement	(707)	(737)
Accumulated other comprehensive loss	(11,637)	(11,900)
Treasury stock	(137,112)	(133,379)
Retained earnings	127,544	123,811
Noncontrolling interest	275	272
TOTAL SHAREHOLDERS’ EQUITY	51,443	50,559
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 122,639	$ 122,370

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - shares shares in Millions	Dec. 31, 2024	Jun. 30, 2024
Statement of Financial Position [Abstract]
Common stock, issued (in shares)	4,009.2	4,009.2

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Millions	Total	Common Stock	Preferred Stock	Additional Paid-In Capital	Reserve for ESOP Debt Retirement	Accumulated Other Comprehensive Income/(Loss)	Treasury Stock	Retained Earnings	Noncontrolling Interest
Beginning balance (in shares) at Jun. 30, 2023		2,362,120
Beginning balance at Jun. 30, 2023	$ 47,065	$ 4,009	$ 819	$ 66,556	$ (821)	$ (12,220)	$ (129,736)	$ 118,170	$ 288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	8,049							7,988	60
Other comprehensive income/(loss)	51					53			(2)
Dividends and dividend equivalents:
Common	(4,450)							(4,450)
Preferred	(140)							(140)
Treasury stock purchases (in shares)		(16,722)
Treasury stock purchases	(2,516)						(2,516)
Employee stock plans (in shares)		6,351
Employee stock plans	734			378			356
Preferred stock conversions (in shares)		1,273
Preferred stock conversions	0		(10)	1			9
ESOP debt impacts	87				39			48
Noncontrolling interest, net	(52)								(52)
Ending balance (in shares) at Dec. 31, 2023		2,353,021
Ending balance at Dec. 31, 2023	48,829	$ 4,009	809	66,935	(782)	(12,167)	(131,887)	121,617	294
Beginning balance (in shares) at Sep. 30, 2023		2,356,886
Beginning balance at Sep. 30, 2023	48,014	$ 4,009	812	66,822	(782)	(12,583)	(131,029)	120,443	321
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	3,493							3,468	25
Other comprehensive income/(loss)	416					416
Dividends and dividend equivalents:
Common	(2,225)							(2,225)
Preferred	(70)							(70)
Treasury stock purchases (in shares)		(6,879)
Treasury stock purchases	(1,008)						(1,008)
Employee stock plans (in shares)		2,630
Employee stock plans	260			113			147
Preferred stock conversions (in shares)		385
Preferred stock conversions	0		(3)				3
Noncontrolling interest, net	(52)								(52)
Ending balance (in shares) at Dec. 31, 2023		2,353,021
Ending balance at Dec. 31, 2023	48,829	$ 4,009	809	66,935	(782)	(12,167)	(131,887)	121,617	294
Beginning balance (in shares) at Jun. 30, 2024		2,357,051
Beginning balance at Jun. 30, 2024	50,559	$ 4,009	798	67,684	(737)	(11,900)	(133,379)	123,811	272
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	8,646							8,589	56
Other comprehensive income/(loss)	260					263			(3)
Dividends and dividend equivalents:
Common	(4,754)							(4,754)
Preferred	(144)							(144)
Treasury stock purchases (in shares)		(26,269)
Treasury stock purchases	(4,462)						(4,462)
Employee stock plans (in shares)		12,827
Employee stock plans	1,318			598			720
Preferred stock conversions (in shares)		1,243
Preferred stock conversions	0		(10)	1			9
ESOP debt impacts	71				30			41
Noncontrolling interest, net	(51)								(51)
Ending balance (in shares) at Dec. 31, 2024		2,344,852
Ending balance at Dec. 31, 2024	51,443	$ 4,009	788	68,283	(707)	(11,637)	(137,112)	127,544	275
Beginning balance (in shares) at Sep. 30, 2024		2,355,042
Beginning balance at Sep. 30, 2024	52,141	$ 4,009	791	68,102	(707)	(10,893)	(134,823)	125,361	300
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	4,659							4,630	29
Other comprehensive income/(loss)	(747)					(744)			(3)
Dividends and dividend equivalents:
Common	(2,375)							(2,375)
Preferred	(72)							(72)
Treasury stock purchases (in shares)		(14,716)
Treasury stock purchases	(2,520)						(2,520)
Employee stock plans (in shares)		4,057
Employee stock plans	408			181			228
Preferred stock conversions (in shares)		469
Preferred stock conversions	0		(3)				3
Noncontrolling interest, net	(51)								(51)
Ending balance (in shares) at Dec. 31, 2024		2,344,852
Ending balance at Dec. 31, 2024	$ 51,443	$ 4,009	$ 788	$ 68,283	$ (707)	$ (11,637)	$ (137,112)	$ 127,544	$ 275

Consolidated Statements of Sh_2

Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]
Dividends and dividend equivalents, common stock (in dollars per share)	$ 1.0065	$ 0.9407	$ 2.013	$ 1.8814
Dividends and dividend equivalents, preferred stock (in dollars per share)	$ 1.0065	$ 0.9407	$ 2.013	$ 1.8814

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Statement of Cash Flows [Abstract]
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD	$ 9,482	$ 8,246
OPERATING ACTIVITIES
Net earnings	8,646	8,049
Depreciation and amortization	1,434	1,423
Share-based compensation expense	241	275
Deferred income taxes	221	(154)
Loss/(gain) on sale of assets	787	(3)
Indefinite-lived intangible asset impairment charge	0	1,341
Change in accounts receivable	(262)	(839)
Change in inventories	(170)	(32)
Change in accounts payable and accrued and other liabilities	(1,157)	302
Change in other operating assets and liabilities	(748)	(704)
Other	135	346
TOTAL OPERATING ACTIVITIES	9,127	10,004
INVESTING ACTIVITIES
Capital expenditures	(1,918)	(1,742)
Proceeds from asset sales	47	8
Acquisitions, net of cash acquired	(6)	0
Other investing activity	(153)	(489)
TOTAL INVESTING ACTIVITIES	(2,029)	(2,224)
FINANCING ACTIVITIES
Dividends to shareholders	(4,886)	(4,578)
Additions to short-term debt with original maturities of more than three months	5,905	2,798
Reductions in short-term debt with original maturities of more than three months	(571)	(5,862)
Net additions/(reductions) to other short-term debt	(2,705)	3,740
Additions to long-term debt	995	254
Reductions in long-term debt	(1,478)	(2,335)
Treasury stock purchases	(4,449)	(2,503)
Impact of stock options and other	985	397
TOTAL FINANCING ACTIVITIES	(6,205)	(8,087)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH	(144)	(49)
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	748	(356)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD	$ 10,230	$ 7,890

Basis of Presentation

Basis of Presentation	6 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of PresentationThe accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries ("the Company," "Procter & Gamble," "P&G," "we" or "our") should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024. We have prepared these statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim financial information. Note that certain columns and rows may not add due to rounding. In the opinion of management, the accompanying Consolidated Financial Statements contain all normal recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.

New Accounting Pronouncements a

New Accounting Pronouncements and Policies	6 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
New Accounting Pronouncements and Policies	New Accounting Pronouncements and Policies In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-07, “Segment Reporting: Improvements to Reportable Segment Disclosures.” This guidance requires disclosure of incremental segment information on an annual and interim basis. This amendment is effective for our fiscal year ending June 30, 2025 and our interim periods within the fiscal year ending June 30, 2026. The guidance will require additional disclosures in the Segment Information footnote, but will not have a material impact on our Consolidated Financial Statements. In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures.” This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. We are currently assessing the impact of this guidance on our disclosures. In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization, and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028 and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures. No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.

Segment Information

Segment Information	6 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of: • Beauty : Hair Care (Conditioners, Shampoos, Styling Aids, Treatments); Personal Care (Antiperspirants and Deodorants, Personal Cleansing); Skin Care (Facial Moisturizers, Cleaners and Treatments); • Grooming : Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming); • Health Care : Oral Care (Toothbrushes, Toothpastes, Other Oral Care); Personal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care); • Fabric & Home Care : Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&G Professional, Surface Care); and • Baby, Feminine & Family Care : Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence, Menstrual Care); Family Care (Paper Towels, Tissues, Toilet Paper). Operating segments as a percentage of consolidated net sales are as follows: % of Net sales by operating segment (1) Three Months Ended December 31 Six Months Ended December 31 2024 2023 2024 2023 Fabric Care 23 % 23 % 23 % 23 % Home Care 12 % 12 % 12 % 12 % Baby Care 9 % 9 % 9 % 10 % Family Care 9 % 9 % 9 % 8 % Hair Care 9 % 9 % 9 % 9 % Grooming 8 % 8 % 8 % 8 % Oral Care 9 % 9 % 8 % 8 % Personal Health Care 6 % 6 % 7 % 7 % Feminine Care 6 % 6 % 6 % 6 % Personal Care (2) 5 % 5 % 6 % 5 % Skin Care (2) 4 % 4 % 3 % 4 % Total 100 % 100 % 100 % 100 % (1) % of Net sales by operating segment excludes sales recorded in Corporate. (2) Effective July 1, 2024, the Beauty reportable business segment separated Skin and Personal Care into individual operating segments, Skin Care and Personal Care. This transition included separation of the management team, strategic decision-making, innovation plans, financial targets, budgets and management reporting. The following is a summary of reportable segment results: Three Months Ended December 31 Six Months Ended December 31 Net Sales Earnings/(Loss) Before Income Taxes Net Earnings/(Loss) Net Sales Earnings/(Loss) Before Income Taxes Net Earnings/(Loss) Beauty 2024 $ 3,848 $ 996 $ 780 $ 7,741 $ 2,063 $ 1,620 2023 3,849 1,112 868 7,946 2,361 1,839 Grooming 2024 1,752 568 459 3,475 1,090 885 2023 1,734 538 440 3,458 1,071 862 Health Care 2024 3,249 974 758 6,397 1,928 1,499 2023 3,172 932 719 6,245 1,821 1,408 Fabric & Home Care 2024 7,575 1,989 1,567 15,285 4,066 3,188 2023 7,415 2,018 1,577 15,061 4,049 3,146 Baby, Feminine & Family Care 2024 5,298 1,464 1,119 10,400 2,847 2,185 2023 5,146 1,437 1,102 10,332 2,845 2,177 Corporate 2024 159 (146) (24) 322 (1,009) (731) 2023 126 (1,541) (1,214) 270 (1,849) (1,383) Total Company 2024 $ 21,882 $ 5,845 $ 4,659 $ 43,619 $ 10,985 $ 8,646 2023 21,441 4,496 3,493 43,312 10,299 8,049

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill is allocated by reportable segment as follows: Beauty Grooming Health Care Fabric & Home Care Baby, Feminine & Family Care Total Company Goodwill at June 30, 2024 $ 13,723 $ 12,633 $ 7,638 $ 1,810 $ 4,499 $ 40,303 Acquisitions and divestitures — — — — — — Translation and other (139) (104) (107) (11) (44) (405) Goodwill at December 31, 2024 $ 13,584 $ 12,529 $ 7,531 $ 1,799 $ 4,456 $ 39,898 Goodwill decreased from June 30, 2024, primarily due to currency translation. Identifiable intangible assets at December 31, 2024, were comprised of: Gross Carrying Amount Accumulated Amortization Intangible assets with determinable lives $ 8,965 $ (6,684) Intangible assets with indefinite lives 19,552 — Total identifiable intangible assets $ 28,517 $ (6,684) Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives primarily consist of brands. The amortization expense of determinable-lived intangible assets for the three months ended December 31, 2024 and 2023, was $80 and $84, respectively. For the six months ended December 31, 2024 and 2023, amortization expense was $163 and $171, respectively. Goodwill and indefinite-lived intangible assets are not amortized but are tested at least annually for impairment. We use the income method to estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. When appropriate, the market approach, which leverages comparable company revenue and earnings multiples, is weighted with the income approach to estimate fair value. If the resulting fair value is less than the asset's carrying value, that difference represents an impairment. Our annual impairment testing for goodwill and indefinite-lived intangible assets occurs during the three months ended December 31. Other than our Gillette indefinite-lived intangible asset, our goodwill reporting units and indefinite-lived intangible assets have fair values that significantly exceed their underlying carrying values. As previously disclosed, the carrying value of the Gillette indefinite-lived intangible asset was impaired during the fiscal year ended June 30, 2024. The impairment charge arose due to a higher discount rate, weakening of several currencies relative to the U.S. dollar and the impact of a new restructuring program focused primarily in certain Enterprise Markets, including Argentina and Nigeria. Following the impairment charge, the carrying value of the Gillette indefinite-lived intangible asset was equivalent to the estimated fair value as of December 31, 2023. Based on our impairment testing performed during the three months ended December 31, 2024, the Gillette indefinite-lived intangible asset's fair value exceeds its carrying value by greater than 10%. As of December 31, 2024, the carrying value of the Gillette indefinite-lived intangible asset was $12.8 billion. Adverse changes in the business or in the macroeconomic environment, including foreign currency devaluation, increasing global inflation, or market contraction from an economic recession, could reduce the underlying cash flows used to estimate the fair value of the Gillette indefinite-lived intangible asset and trigger a further impairment charge. The most significant assumptions utilized in the determination of the estimated fair value of the Gillette indefinite-lived intangible asset are the net sales growth rates (including residual growth rates), discount rate and royalty rates. Net sales growth rates could be negatively impacted by reductions or changes in demand for our Gillette products, which may be caused by, among other things: changes in the use and frequency of grooming products, shifts in demand away from one or more of our higher priced products to lower priced products or potential supply chain constraints. In addition, relative global and country/regional macroeconomic factors could result in additional and prolonged devaluation of other countries' currencies relative to the U.S. dollar. The residual growth rates represent the expected rate at which the Gillette brand is expected to grow beyond the shorter-term business planning period. The residual growth rates utilized in our fair value estimates are consistent with the brand operating plans and approximate expected long-term category market growth rates. The residual growth rate depends on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment. The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S. The royalty rate used to determine the estimated fair value for the Gillette indefinite-lived intangible asset is driven by historical and estimated future profitability of the underlying Gillette business. The royalty rate may be impacted by significant adverse changes in long-term operating margins. We performed a sensitivity analysis for the Gillette indefinite-lived intangible asset as part of our annual impairment testing during the three months ended December 31, 2024, utilizing reasonably possible changes in the assumptions for the discount rate, the short-term and residual growth rates and the royalty rate to demonstrate the potential impacts to estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate. Approximate Percent Change in Estimated Fair Value +25 bps Discount Rate -25 bps Growth Rates -50 bps Royalty Rate Gillette indefinite-lived intangible asset (5) % (5) % (4) %

Earnings Per Share

Earnings Per Share	6 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble by the diluted weighted average number of common shares outstanding during the period. The diluted shares include the dilutive effect of stock options and other share-based awards based on the treasury stock method and the assumed conversion of preferred stock. Net earnings per common share were calculated as follows: CONSOLIDATED AMOUNTS Three Months Ended December 31 Six Months Ended December 31 2024 2023 2024 2023 Net earnings $ 4,659 $ 3,493 $ 8,646 $ 8,049 Less: Net earnings attributable to noncontrolling interests 29 25 56 60 Net earnings attributable to P&G 4,630 3,468 8,589 7,988 Less: Preferred dividends 72 70 144 140 Net earnings attributable to P&G available to common shareholders (Basic) $ 4,558 $ 3,398 $ 8,445 $ 7,849 SHARES IN MILLIONS Basic weighted average common shares outstanding 2,351.9 2,358.0 2,354.1 2,359.0 Add effect of dilutive securities: Convertible preferred shares (1) 71.3 73.9 71.6 74.3 Stock options and other unvested equity awards (2) 34.9 36.4 36.4 38.5 Diluted weighted average common shares outstanding 2,458.1 2,468.4 2,462.1 2,471.8 NET EARNINGS PER COMMON SHARE Basic $ 1.94 $ 1.44 $ 3.59 $ 3.33 Diluted $ 1.88 $ 1.40 $ 3.49 $ 3.23 (1) An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. (2) Excludes approximately 8 million and 9 million for the three months ended December 31, 2024 and 2023 respectively, and 4 million and 5 million for the six months ended December 31, 2024 and 2023 respectively, of weighted average stock options outstanding because the exercise price of these options was greater than their average market value or their effect was antidilutive.

Share-Based Compensation and Po

Share-Based Compensation and Postretirement Benefits	6 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Share-Based Compensation and Postretirement Benefits	Share-Based Compensation and Postretirement Benefits The following table provides a summary of our share-based compensation expense and postretirement benefit impacts: Three Months Ended December 31 Six Months Ended December 31 2024 2023 2024 2023 Share-based compensation expense $ 136 $ 150 $ 241 $ 275 Net periodic benefit cost for pension benefits 26 52 63 109 Net periodic benefit (credit) for other retiree benefits (180) (156) (360) (311)

Risk Management Activities and

Risk Management Activities and Fair Value Measurements	6 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Risk Management Activities and Fair Value Measurements	Risk Management Activities and Fair Value Measurements As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the six months ended December 31, 2024. The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. Except for the impairment of the Gillette indefinite-lived intangible asset discussed in Note 4, there were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the six months ended December 31, 2024 or during the fiscal year ended June 30, 2024. Cash equivalents were $8.7 billion and $8.0 billion as of December 31, 2024 and June 30, 2024, respectively, and are classified as Level 1 within the fair value hierarchy. The Company had no other material investments in debt or equity securities during the periods presented. The fair value of long-term debt was $27.3 billion and $27.7 billion as of December 31, 2024 and June 30, 2024, respectively. This includes the current portion of long-term debt instruments ($3.3 billion and $3.8 billion as of December 31, 2024 and June 30, 2024, respectively). Certain long-term debt (debt designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments. Disclosures about Financial Instruments The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2024 and June 30, 2024, are as follows: Notional Amount Fair Value Asset Fair Value (Liability) December 31, 2024 June 30, 2024 December 31, 2024 June 30, 2024 December 31, 2024 June 30, 2024 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ 2,914 $ 2,993 $ — $ — $ (215) $ (325) DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS Foreign currency interest rate contracts $ 13,054 $ 10,140 $ 545 $ 119 $ — $ (31) TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS $ 15,968 $ 13,133 $ 545 $ 119 $ (215) $ (356) DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ 3,359 $ 3,192 $ 1 $ 1 $ (40) $ (23) TOTAL DERIVATIVES AT FAIR VALUE $ 19,326 $ 16,325 $ 546 $ 120 $ (255) $ (379) The fair value of the interest rate derivative asset/(liability) directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $2.7 billion as of December 31, 2024 and June 30, 2024. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $10.4 billion and $11.9 billion as of December 31, 2024 and June 30, 2024, respectively. The increase in notional balance of the derivative instruments designated as net investment hedges is primarily driven by the Company's decision to leverage favorable interest rate spreads in the foreign currency swap market. Derivative assets Derivative liabilities Certain of the Company's financial instruments used in hedging transactions are governed by industry standard netting and collateral agreements with counterparties. If the Company's credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangements. The aggregate fair value of the instruments covered by these contractual features that are in a liability position was $33 and $307 as of December 31, 2024 and June 30, 2024, respectively. The Company has not been required to post collateral as a result of these contractual features. Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows: Amount of Gain/(Loss) Recognized in OCI on Derivatives Three Months Ended December 31 Six Months Ended December 31 2024 2023 2024 2023 DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2) Foreign currency interest rate contracts $ 857 $ (487) $ 356 $ (202) (1) For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $57 and $62 for the three months ended December 31, 2024 and 2023, respectively. The amount of gain excluded from effectiveness testing was $107 and $130 for the six months ended December 31, 2024 and 2023, respectively. (2) In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $825 and $(504) for the three months ended December 31, 2024 and 2023, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $215 and $(159) for the six months ended December 31, 2024 and 2023, respectively. Amount of Gain/(Loss) Recognized in Earnings Three Months Ended December 31 Six Months Ended December 31 2024 2023 2024 2023 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ 34 $ 117 $ 110 $ 128 DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ (174) $ 128 $ (48) $ 57 The gains on the derivatives in fair value hedging relationships are fully offset by the mark-to-market impact of the related exposure. These are both recognized in Interest expense. The gains/(losses) on derivatives not designated as hedging instruments are substantially offset by the currency mark-to-market of the related exposure. These are both recognized in Selling, general and administrative expense (SG&A).

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income/(Loss)	6 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Accumulated Other Comprehensive Income/(Loss)	Accumulated Other Comprehensive Income/(Loss) The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component: Investment Securities Postretirement Benefit Plans Foreign Currency Translation Total AOCI Balance at June 30, 2024, net of tax $ 10 $ 613 $ (12,522) $ (11,900) Other comprehensive income/(loss), before tax: OCI before reclassifications 1 38 (362) (323) Amounts reclassified to the Consolidated Statement of Earnings — (38) 752 714 Total other comprehensive income/(loss), before tax 1 — 390 391 Tax effect — 3 (134) (131) Total other comprehensive income/(loss), net of tax 1 3 256 260 Less: OCI attributable to noncontrolling interests, net of tax — 2 (5) (3) Balance at December 31, 2024, net of tax $ 11 $ 614 $ (12,262) $ (11,637) The below provides additional details on amounts reclassified from AOCI into the Consolidated Statement of Earnings: • Postretirement benefit plan amounts are reclassified from AOCI into Other non-operating income/(expense), net and included in the computation of net periodic postretirement costs. • Foreign currency translation amounts are reclassified from AOCI into Other non-operating income/(expense), net. These amounts relate to accumulated foreign currency translation losses recognized due to the substantial liquidation of operations in Argentina recorded in the period ended September 30, 2024.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and trademark matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows. Income Tax Uncertainties The Company is present in about 70 countries and over 150 taxable jurisdictions and, at any point in time, has 30–40 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2010 and forward. We are generally not able to reliably estimate the timing and ultimate settlement amounts until the close of an audit. Based on information currently available, we do not anticipate over the next 12-month period any significant audit activity concluding related to uncertain tax positions for which we have existing accrued liabilities. Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.

Supplier Finance Programs

Supplier Finance Programs	6 Months Ended
	Dec. 31, 2024
Payables and Accruals [Abstract]
Supplier Finance Programs	Supplier Finance Programs The Company has an ongoing program to negotiate extended payment terms with its suppliers consistent with market practices. The Company also supports a Supply Chain Finance program (“SCF”) with several global financial institutions. Under SCF, the Company maintains an accounts payable system to facilitate participating suppliers' ability to sell receivables from the Company to a SCF bank. These participating suppliers negotiate their sales of receivables arrangements directly with the respective SCF bank. The Company is not party to those agreements, but the SCF banks allow the suppliers to utilize the Company’s creditworthiness in establishing credit spreads and associated costs. Under this model, this arrangement generally provides the suppliers with more favorable terms than they would be able to secure on their own. The Company has no economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier chooses to participate in SCF, the supplier selects which individual Company invoices to sell to the SCF bank. The Company’s obligations to its suppliers, including the amounts due and scheduled payment dates, are not impacted by the supplier’s decisions to finance amounts under these arrangements. The Company does not provide any form of guarantee under these financing arrangements. Our payment terms for suppliers under this program generally range from 60 to 180 days. All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable in our Consolidated Balance Sheets, and the associated payments are included in operating activities within our Consolidated Statements of Cash Flows. The amount due to suppliers participating in SCF and included in Accounts payable

Restructuring Program

Restructuring Program	6 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring Program	Restructuring Program The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually. Consistent with our historical policies for restructuring-type activities, the restructuring program charges will be funded by and included within Corporate for management and segment reporting. In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring with the substantial liquidation of its operations in Argentina and recorded approximately $0.8 billion after tax of incremental charges, comprised primarily of non-cash charges for accumulated foreign currency translation losses previously included in Accumulated other comprehensive income/(loss). The total incremental restructuring charges incurred under the program beginning in the three-month period ended December 31, 2023, through the three-month period ended September 30, 2024, were approximately $1.2 billion after tax. For the three months ended December 31, 2024, the Company incurred total before tax charges of $47 including $28 in Costs of products sold, $25 in SG&A and $(5) in Other non-operating income/(expense). For the six months ended December 31, 2024, the Company incurred charges of $933 including $69 in Costs of products sold, $79 in SG&A and $785 in Other non-operating income/(expense). The following table presents restructuring activity for the six months ended December 31, 2024: Separation Costs Asset-Related Costs Other Costs Total RESERVE JUNE 30, 2024 $ 133 $ — $ 32 $ 166 Costs incurred for the three months ended September 30, 2024 16 30 839 886 Costs incurred for the three months ended December 31, 2024 25 9 14 47 Costs incurred for the six months ended December 31, 2024 41 39 853 933 Costs paid/settled for the six months ended December 31, 2024 (58) (39) (823) (921) RESERVE DECEMBER 31, 2024 $ 115 $ — $ 62 $ 178 Separation Costs Employee separation costs relate to severance packages that are primarily voluntary and the amounts calculated are based on salary levels and past service periods. Asset-Related Costs Asset-related costs consist of both asset write-downs and accelerated depreciation for manufacturing consolidations. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or for disposal. These assets are written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period. Other Costs Other restructuring-type charges are incurred as a direct result of the restructuring plan. Such charges include accumulated foreign currency translation losses, asset removal and termination of contracts.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ 4,630	$ 3,468	$ 8,589	$ 7,988

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

New Accounting Pronouncements_2

New Accounting Pronouncements and Policies (Policies)	6 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
New Accounting Pronouncements and Policies	New Accounting Pronouncements and Policies In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-07, “Segment Reporting: Improvements to Reportable Segment Disclosures.” This guidance requires disclosure of incremental segment information on an annual and interim basis. This amendment is effective for our fiscal year ending June 30, 2025 and our interim periods within the fiscal year ending June 30, 2026. The guidance will require additional disclosures in the Segment Information footnote, but will not have a material impact on our Consolidated Financial Statements. In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures.” This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. We are currently assessing the impact of this guidance on our disclosures. In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization, and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028 and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures. No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	Operating segments as a percentage of consolidated net sales are as follows: % of Net sales by operating segment (1) Three Months Ended December 31 Six Months Ended December 31 2024 2023 2024 2023 Fabric Care 23 % 23 % 23 % 23 % Home Care 12 % 12 % 12 % 12 % Baby Care 9 % 9 % 9 % 10 % Family Care 9 % 9 % 9 % 8 % Hair Care 9 % 9 % 9 % 9 % Grooming 8 % 8 % 8 % 8 % Oral Care 9 % 9 % 8 % 8 % Personal Health Care 6 % 6 % 7 % 7 % Feminine Care 6 % 6 % 6 % 6 % Personal Care (2) 5 % 5 % 6 % 5 % Skin Care (2) 4 % 4 % 3 % 4 % Total 100 % 100 % 100 % 100 % (1) % of Net sales by operating segment excludes sales recorded in Corporate. (2) Effective July 1, 2024, the Beauty reportable business segment separated Skin and Personal Care into individual operating segments, Skin Care and Personal Care. This transition included separation of the management team, strategic decision-making, innovation plans, financial targets, budgets and management reporting.
Reconciliation of Revenue from Segments to Consolidated	The following is a summary of reportable segment results: Three Months Ended December 31 Six Months Ended December 31 Net Sales Earnings/(Loss) Before Income Taxes Net Earnings/(Loss) Net Sales Earnings/(Loss) Before Income Taxes Net Earnings/(Loss) Beauty 2024 $ 3,848 $ 996 $ 780 $ 7,741 $ 2,063 $ 1,620 2023 3,849 1,112 868 7,946 2,361 1,839 Grooming 2024 1,752 568 459 3,475 1,090 885 2023 1,734 538 440 3,458 1,071 862 Health Care 2024 3,249 974 758 6,397 1,928 1,499 2023 3,172 932 719 6,245 1,821 1,408 Fabric & Home Care 2024 7,575 1,989 1,567 15,285 4,066 3,188 2023 7,415 2,018 1,577 15,061 4,049 3,146 Baby, Feminine & Family Care 2024 5,298 1,464 1,119 10,400 2,847 2,185 2023 5,146 1,437 1,102 10,332 2,845 2,177 Corporate 2024 159 (146) (24) 322 (1,009) (731) 2023 126 (1,541) (1,214) 270 (1,849) (1,383) Total Company 2024 $ 21,882 $ 5,845 $ 4,659 $ 43,619 $ 10,985 $ 8,646 2023 21,441 4,496 3,493 43,312 10,299 8,049

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Goodwill is allocated by reportable segment as follows: Beauty Grooming Health Care Fabric & Home Care Baby, Feminine & Family Care Total Company Goodwill at June 30, 2024 $ 13,723 $ 12,633 $ 7,638 $ 1,810 $ 4,499 $ 40,303 Acquisitions and divestitures — — — — — — Translation and other (139) (104) (107) (11) (44) (405) Goodwill at December 31, 2024 $ 13,584 $ 12,529 $ 7,531 $ 1,799 $ 4,456 $ 39,898
Schedule of Finite-Lived Intangible Assets	Identifiable intangible assets at December 31, 2024, were comprised of: Gross Carrying Amount Accumulated Amortization Intangible assets with determinable lives $ 8,965 $ (6,684) Intangible assets with indefinite lives 19,552 — Total identifiable intangible assets $ 28,517 $ (6,684)
Schedule of Indefinite-Lived Intangible Assets	Identifiable intangible assets at December 31, 2024, were comprised of: Gross Carrying Amount Accumulated Amortization Intangible assets with determinable lives $ 8,965 $ (6,684) Intangible assets with indefinite lives 19,552 — Total identifiable intangible assets $ 28,517 $ (6,684)
Schedule of Potential Impacts to Estimated Fair Values	The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate. Approximate Percent Change in Estimated Fair Value +25 bps Discount Rate -25 bps Growth Rates -50 bps Royalty Rate Gillette indefinite-lived intangible asset (5) % (5) % (4) %

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	Net earnings per common share were calculated as follows: CONSOLIDATED AMOUNTS Three Months Ended December 31 Six Months Ended December 31 2024 2023 2024 2023 Net earnings $ 4,659 $ 3,493 $ 8,646 $ 8,049 Less: Net earnings attributable to noncontrolling interests 29 25 56 60 Net earnings attributable to P&G 4,630 3,468 8,589 7,988 Less: Preferred dividends 72 70 144 140 Net earnings attributable to P&G available to common shareholders (Basic) $ 4,558 $ 3,398 $ 8,445 $ 7,849 SHARES IN MILLIONS Basic weighted average common shares outstanding 2,351.9 2,358.0 2,354.1 2,359.0 Add effect of dilutive securities: Convertible preferred shares (1) 71.3 73.9 71.6 74.3 Stock options and other unvested equity awards (2) 34.9 36.4 36.4 38.5 Diluted weighted average common shares outstanding 2,458.1 2,468.4 2,462.1 2,471.8 NET EARNINGS PER COMMON SHARE Basic $ 1.94 $ 1.44 $ 3.59 $ 3.33 Diluted $ 1.88 $ 1.40 $ 3.49 $ 3.23 (1) An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. (2) Excludes approximately 8 million and 9 million for the three months ended December 31, 2024 and 2023 respectively, and 4 million and 5 million for the six months ended December 31, 2024 and 2023 respectively, of weighted average stock options outstanding because the exercise price of these options was greater than their average market value or their effect was antidilutive.

Share-Based Compensation and _2

Share-Based Compensation and Postretirement Benefits (Tables)	6 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Compensation and Employee Benefit Plans	The following table provides a summary of our share-based compensation expense and postretirement benefit impacts: Three Months Ended December 31 Six Months Ended December 31 2024 2023 2024 2023 Share-based compensation expense $ 136 $ 150 $ 241 $ 275 Net periodic benefit cost for pension benefits 26 52 63 109 Net periodic benefit (credit) for other retiree benefits (180) (156) (360) (311)

Risk Management Activities an_2

Risk Management Activities and Fair Value Measurements (Tables)	6 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2024 and June 30, 2024, are as follows: Notional Amount Fair Value Asset Fair Value (Liability) December 31, 2024 June 30, 2024 December 31, 2024 June 30, 2024 December 31, 2024 June 30, 2024 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ 2,914 $ 2,993 $ — $ — $ (215) $ (325) DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS Foreign currency interest rate contracts $ 13,054 $ 10,140 $ 545 $ 119 $ — $ (31) TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS $ 15,968 $ 13,133 $ 545 $ 119 $ (215) $ (356) DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ 3,359 $ 3,192 $ 1 $ 1 $ (40) $ (23) TOTAL DERIVATIVES AT FAIR VALUE $ 19,326 $ 16,325 $ 546 $ 120 $ (255) $ (379)
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)	Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows: Amount of Gain/(Loss) Recognized in OCI on Derivatives Three Months Ended December 31 Six Months Ended December 31 2024 2023 2024 2023 DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2) Foreign currency interest rate contracts $ 857 $ (487) $ 356 $ (202) (1) For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $57 and $62 for the three months ended December 31, 2024 and 2023, respectively. The amount of gain excluded from effectiveness testing was $107 and $130 for the six months ended December 31, 2024 and 2023, respectively. (2) In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $825 and $(504) for the three months ended December 31, 2024 and 2023, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $215 and $(159) for the six months ended December 31, 2024 and 2023, respectively.
Derivative Instruments, Gain (Loss)	Amount of Gain/(Loss) Recognized in Earnings Three Months Ended December 31 Six Months Ended December 31 2024 2023 2024 2023 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ 34 $ 117 $ 110 $ 128 DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ (174) $ 128 $ (48) $ 57

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income/(Loss) (Tables)	6 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component: Investment Securities Postretirement Benefit Plans Foreign Currency Translation Total AOCI Balance at June 30, 2024, net of tax $ 10 $ 613 $ (12,522) $ (11,900) Other comprehensive income/(loss), before tax: OCI before reclassifications 1 38 (362) (323) Amounts reclassified to the Consolidated Statement of Earnings — (38) 752 714 Total other comprehensive income/(loss), before tax 1 — 390 391 Tax effect — 3 (134) (131) Total other comprehensive income/(loss), net of tax 1 3 256 260 Less: OCI attributable to noncontrolling interests, net of tax — 2 (5) (3) Balance at December 31, 2024, net of tax $ 11 $ 614 $ (12,262) $ (11,637)

Restructuring Program (Tables)

Restructuring Program (Tables)	6 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve by Type of Cost	The following table presents restructuring activity for the six months ended December 31, 2024: Separation Costs Asset-Related Costs Other Costs Total RESERVE JUNE 30, 2024 $ 133 $ — $ 32 $ 166 Costs incurred for the three months ended September 30, 2024 16 30 839 886 Costs incurred for the three months ended December 31, 2024 25 9 14 47 Costs incurred for the six months ended December 31, 2024 41 39 853 933 Costs paid/settled for the six months ended December 31, 2024 (58) (39) (823) (921) RESERVE DECEMBER 31, 2024 $ 115 $ — $ 62 $ 178

Segment Information - Additiona

Segment Information - Additional Information (Details)	6 Months Ended
	Dec. 31, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	5

Segment Information - Percent O

Segment Information - Percent Of Sales By Business Unit (Details) - Revenue Benchmark - Product Concentration Risk - Operating Segments	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Concentration risk (in percent)	100%	100%	100%	100%
Fabric & Home Care | Fabric Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	23%	23%	23%	23%
Fabric & Home Care | Home Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	12%	12%	12%	12%
Baby, Feminine & Family Care | Baby Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	9%	9%	9%	10%
Baby, Feminine & Family Care | Family Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	9%	9%	9%	8%
Baby, Feminine & Family Care | Feminine Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	6%	6%	6%	6%
Beauty | Hair Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	9%	9%	9%	9%
Beauty | Personal Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	5%	5%	6%	5%
Beauty | Skin Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	4%	4%	3%	4%
Grooming | Grooming
Segment Reporting Information [Line Items]
Concentration risk (in percent)	8%	8%	8%	8%
Health Care | Oral Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	9%	9%	8%	8%
Health Care | Personal Health Care
Segment Reporting Information [Line Items]
Concentration risk (in percent)	6%	6%	7%	7%

Segment Information - Global Se

Segment Information - Global Segment Results (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Net Sales	$ 21,882	$ 21,441	$ 43,619	$ 43,312
Earnings/(Loss) Before Income Taxes	5,845	4,496	10,985	10,299
Net Earnings/(Loss)	4,659	3,493	8,646	8,049
Corporate
Segment Reporting Information [Line Items]
Net Sales	159	126	322	270
Earnings/(Loss) Before Income Taxes	(146)	(1,541)	(1,009)	(1,849)
Net Earnings/(Loss)	(24)	(1,214)	(731)	(1,383)
Beauty | Operating Segments
Segment Reporting Information [Line Items]
Net Sales	3,848	3,849	7,741	7,946
Earnings/(Loss) Before Income Taxes	996	1,112	2,063	2,361
Net Earnings/(Loss)	780	868	1,620	1,839
Grooming | Operating Segments
Segment Reporting Information [Line Items]
Net Sales	1,752	1,734	3,475	3,458
Earnings/(Loss) Before Income Taxes	568	538	1,090	1,071
Net Earnings/(Loss)	459	440	885	862
Health Care | Operating Segments
Segment Reporting Information [Line Items]
Net Sales	3,249	3,172	6,397	6,245
Earnings/(Loss) Before Income Taxes	974	932	1,928	1,821
Net Earnings/(Loss)	758	719	1,499	1,408
Fabric & Home Care | Operating Segments
Segment Reporting Information [Line Items]
Net Sales	7,575	7,415	15,285	15,061
Earnings/(Loss) Before Income Taxes	1,989	2,018	4,066	4,049
Net Earnings/(Loss)	1,567	1,577	3,188	3,146
Baby, Feminine & Family Care | Operating Segments
Segment Reporting Information [Line Items]
Net Sales	5,298	5,146	10,400	10,332
Earnings/(Loss) Before Income Taxes	1,464	1,437	2,847	2,845
Net Earnings/(Loss)	$ 1,119	$ 1,102	$ 2,185	$ 2,177

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details) $ in Millions	6 Months Ended
	Dec. 31, 2024 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 40,303
Acquisitions and divestitures	0
Translation and other	(405)
Ending balance	39,898
Beauty
Goodwill [Roll Forward]
Beginning balance	13,723
Acquisitions and divestitures	0
Translation and other	(139)
Ending balance	13,584
Grooming
Goodwill [Roll Forward]
Beginning balance	12,633
Acquisitions and divestitures	0
Translation and other	(104)
Ending balance	12,529
Health Care
Goodwill [Roll Forward]
Beginning balance	7,638
Acquisitions and divestitures	0
Translation and other	(107)
Ending balance	7,531
Fabric & Home Care
Goodwill [Roll Forward]
Beginning balance	1,810
Acquisitions and divestitures	0
Translation and other	(11)
Ending balance	1,799
Baby, Feminine & Family Care
Goodwill [Roll Forward]
Beginning balance	4,499
Acquisitions and divestitures	0
Translation and other	(44)
Ending balance	$ 4,456

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Intangible Assets (Details) $ in Millions	Dec. 31, 2024 USD ($)
Intangible assets with determinable lives
Gross Carrying Amount	$ 8,965
Accumulated Amortization	(6,684)
Intangible assets with indefinite lives
Gross Carrying Amount	19,552
Gross Carrying Amount	$ 28,517

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible asset amortization	$ 80	$ 84	$ 163	$ 171
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset	$ 19,552		$ 19,552
Percentage of fair value in excess of carrying value	10%		10%
Gillette
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset	$ 12,800		$ 12,800

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Fair Value Impacts (Details) - Intangible Assets with Indefinite Lives - Gillette	Dec. 31, 2024
+25 bps Discount Rate
Indefinite-Lived Intangible Assets [Line Items]
Change in estimated fair value (in percent)	(0.05)
-25 bps Growth Rates
Indefinite-Lived Intangible Assets [Line Items]
Change in estimated fair value (in percent)	(0.05)
-50 bps Royalty Rate
Indefinite-Lived Intangible Assets [Line Items]
Change in estimated fair value (in percent)	(0.04)

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended		6 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
CONSOLIDATED AMOUNTS
Net earnings		$ 4,659	$ 3,493	$ 8,646	$ 8,049
Less: Net earnings attributable to noncontrolling interests		29	25	56	60
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE		4,630	3,468	8,589	7,988
Less: Preferred dividends		72	70	144	140
Net earnings attributable to P&G available to common shareholders (Basic)		$ 4,558	$ 3,398	$ 8,445	$ 7,849
SHARES IN MILLIONS
Basic weighted average common shares outstanding (in shares)		2,351.9	2,358	2,354.1	2,359
Add effect of dilutive securities:
Convertible preferred shares (in shares)		71.3	73.9	71.6	74.3
Stock options and other unvested equity awards (in shares)		34.9	36.4	36.4	38.5
Diluted weighted average common shares outstanding (in shares)		2,458.1	2,468.4	2,462.1	2,471.8
NET EARNINGS PER COMMON SHARE
Basic (in dollars per share)	[1]	$ 1.94	$ 1.44	$ 3.59	$ 3.33
Diluted (in dollars per share)	[1]	$ 1.88	$ 1.40	$ 3.49	$ 3.23
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)		8	9	4	5
[1] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

Share-Based Compensation and _3

Share-Based Compensation and Postretirement Benefits (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Retirement Benefits [Abstract]
Share-based compensation expense	$ 136	$ 150	$ 241	$ 275
Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost (credit)	26	52	63	109
Other Retiree Benefits
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost (credit)	$ (180)	$ (156)	$ (360)	$ (311)

Risk Management Activities an_3

Risk Management Activities and Fair Value Measurements - Additional Information (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Cash equivalents	$ 8,700	$ 8,000
Fair value of long-term debt	27,300	27,700
Current portion of long-term debt instruments	$ 3,300	$ 3,800
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	OTHER NONCURRENT ASSETS, Prepaid expenses and other current assets	OTHER NONCURRENT ASSETS, Prepaid expenses and other current assets
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Accrued and other liabilities, OTHER NONCURRENT LIABILITIES	Accrued and other liabilities, OTHER NONCURRENT LIABILITIES
Collateral already posted, aggregate fair value	$ 33	$ 307
Fair Value Hedging | Underlying, Other
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of the underlying debt obligation	2,700	2,700
Net Investment Hedging | Underlying, Other
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of the underlying debt obligation	$ 10,400	$ 11,900

Risk Management Activities an_4

Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	$ 19,326	$ 16,325
Fair Value Asset	546	120
Fair Value (Liability)	(255)	(379)
Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	15,968	13,133
Fair Value Asset	545	119
Fair Value (Liability)	(215)	(356)
Interest rate contracts | Fair Value Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	2,914	2,993
Fair Value Asset	0	0
Fair Value (Liability)	(215)	(325)
Foreign currency interest rate contracts | Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	3,359	3,192
Fair Value Asset	1	1
Fair Value (Liability)	(40)	(23)
Foreign currency interest rate contracts | Net Investment Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	13,054	10,140
Fair Value Asset	545	119
Fair Value (Liability)	$ 0	$ (31)

Risk Management Activities an_5

Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of gain (loss) excluded from effectiveness testing, which was recognized in earnings	$ 57	$ 62	$ 107	$ 130
Gain/(loss) recognized in AOCI	825	(504)	215	(159)
Foreign currency interest rate contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain/(Loss) Recognized in OCI on Derivatives	$ 857	$ (487)	$ 356	$ (202)

Risk Management Activities an_6

Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Interest rate contracts | Fair Value Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain/(Loss) Recognized in Earnings	$ 34	$ 117	$ 110	$ 128
Foreign currency interest rate contracts | Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain/(Loss) Recognized in Earnings	$ (174)	$ 128	$ (48)	$ 57

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 52,141	$ 48,014	$ 50,559	$ 47,065
Other comprehensive income/(loss), before tax:
OCI before reclassifications			(323)
Amounts reclassified to the Consolidated Statement of Earnings			714
Total other comprehensive income/(loss), before tax			391
Tax effect			(131)
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX	(747)	416	260	51
Less: OCI attributable to noncontrolling interests, net of tax			(3)
Ending balance	51,443	48,829	51,443	48,829
Accumulated Other Comprehensive Income/(Loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(10,893)	(12,583)	(11,900)	(12,220)
Other comprehensive income/(loss), before tax:
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX	(744)	416	263	53
Ending balance	(11,637)	$ (12,167)	(11,637)	$ (12,167)
Investment Securities
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			10
Other comprehensive income/(loss), before tax:
OCI before reclassifications			1
Amounts reclassified to the Consolidated Statement of Earnings			0
Total other comprehensive income/(loss), before tax			1
Tax effect			0
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX			1
Less: OCI attributable to noncontrolling interests, net of tax			0
Ending balance	11		11
Postretirement Benefit Plans
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			613
Other comprehensive income/(loss), before tax:
OCI before reclassifications			38
Amounts reclassified to the Consolidated Statement of Earnings			(38)
Total other comprehensive income/(loss), before tax			0
Tax effect			3
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX			3
Less: OCI attributable to noncontrolling interests, net of tax			2
Ending balance	614		614
Foreign Currency Translation
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			(12,522)
Other comprehensive income/(loss), before tax:
OCI before reclassifications			(362)
Amounts reclassified to the Consolidated Statement of Earnings			752
Total other comprehensive income/(loss), before tax			390
Tax effect			(134)
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX			256
Less: OCI attributable to noncontrolling interests, net of tax			(5)
Ending balance	$ (12,262)		$ (12,262)

Commitments and Contingencies (

Commitments and Contingencies (Details)	6 Months Ended
	Dec. 31, 2024 country audit taxable_jurisdiction
Loss Contingencies [Line Items]
Number of countries with on the ground operations | country	70
Number of taxable jurisdictions | taxable_jurisdiction	150
Minimum
Loss Contingencies [Line Items]
Number of audits underway	30
Maximum
Loss Contingencies [Line Items]
Number of audits underway	40

Supplier Finance Programs (Deta

Supplier Finance Programs (Details) - USD ($) $ in Billions	Dec. 31, 2024	Jun. 30, 2024
Supplier Finance Program [Line Items]
Amount due to suppliers participating in SCF	$ 5.6	$ 5.6
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]	Accounts payable	Accounts payable
Minimum
Supplier Finance Program [Line Items]
Payment terms for suppliers (in days)	60 days
Maximum
Supplier Finance Program [Line Items]
Payment terms for suppliers (in days)	180 days

Restructuring Program - Narrati

Restructuring Program - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended	12 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2024	Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]
Foreign currency translation gain (loss)		$ (800)
Incremental restructuring charges incurred				$ 1,200
Restructuring charges	$ 47	$ 886	$ 933
Selling, General and Administrative Expenses
Restructuring Cost and Reserve [Line Items]
Restructuring charges	25		79
Cost of Sales
Restructuring Cost and Reserve [Line Items]
Restructuring charges	28		69
Other Non-operating Income (Expense)
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(5)		785
Minimum
Restructuring Cost and Reserve [Line Items]
Historical restructuring costs, before tax	250		250
Maximum
Restructuring Cost and Reserve [Line Items]
Historical restructuring costs, before tax	$ 500		$ 500

Restructuring Program - Restruc

Restructuring Program - Restructuring Activity (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2024
Restructuring Reserve [Roll Forward]
Beginning balance		$ 166	$ 166
Cost incurred	$ 47	886	933
Cost paid/settled			(921)
Ending balance	178		178
Separation Costs
Restructuring Reserve [Roll Forward]
Beginning balance		133	133
Cost incurred	25	16	41
Cost paid/settled			(58)
Ending balance	115		115
Asset-Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance		0	0
Cost incurred	9	30	39
Cost paid/settled			(39)
Ending balance	0		0
Other Costs
Restructuring Reserve [Roll Forward]
Beginning balance		32	32
Cost incurred	14	$ 839	853
Cost paid/settled			(823)
Ending balance	$ 62		$ 62